Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06878144 · ClinicalTrials.gov registry record
Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- 300
- Enrollment target
NCT06878144: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT06878144 is a clinical trial that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06878144 has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- 300 participants
- Enrollment target
Study Summary
To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.
Interventions
- BEHAVIORAL Mucormycosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2032-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06878144
The ClinicalTrials.gov registry entry for NCT06878144 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mucormycosis is the first listed.
NCT06878144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06878144 about?
NCT06878144 is a clinical study titled "Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project". To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.
What is the current status of trial NCT06878144?
This trial is currently not yet recruiting. The enrollment target is 300 participants. The study started on 2025-09-30. Estimated completion is 2032-12-31.
What interventions are being tested in trial NCT06878144?
The interventions under investigation include: Mucormycosis (BEHAVIORAL).
Who is sponsoring clinical trial NCT06878144?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.